Liberum Capital Downgrades Advanced Medical Solutions Group (LON:AMS) to Hold

Advanced Medical Solutions Group (LON:AMSGet Rating) was downgraded by stock analysts at Liberum Capital to a “hold” rating in a research note issued to investors on Wednesday, Marketbeat.com reports. They currently have a GBX 296 ($3.61) price objective on the stock. Liberum Capital’s price objective indicates a potential upside of 23.33% from the stock’s previous close.

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 310 ($3.78) target price on shares of Advanced Medical Solutions Group in a research note on Wednesday.

Advanced Medical Solutions Group Price Performance

AMS opened at GBX 240 ($2.93) on Wednesday. The business’s 50-day moving average is GBX 258.11 and its two-hundred day moving average is GBX 262.40. Advanced Medical Solutions Group has a 1 year low of GBX 229 ($2.79) and a 1 year high of GBX 319.50 ($3.89). The company has a debt-to-equity ratio of 4.28, a current ratio of 5.65 and a quick ratio of 4.58. The firm has a market capitalization of ¬£520.58 million, a PE ratio of 3,012.50, a price-to-earnings-growth ratio of 2.77 and a beta of 0.60.

About Advanced Medical Solutions Group

(Get Rating)

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.

See Also

Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.